Printer Friendly

Apo E in Alzheimer's stunts nerve growth.

Many researchers agree that a molecule called apolipoprotein E (apo E) is somehow linked to the development of Alzheimer's disease (SN: 1/1/94, p.8). But they have yet to figure out why inheriting one form of this molecule increases an individual's risk of developing the debilitating dementia. Many people with apo E-IV are more likely to show symptoms of Alzheimer's at younger ages than people who inherit other forms.

Now, experiments involving peripheral nerve cells of rabbits have revealed a key difference between apo E-IV and the more common isoform known as apo E-III in regulating the growth of young nerve cell appendages, or axons. Apo E-III stimulates this growth; apo E-IV does not, says Robert W. Mahley, a cellular and molecular biologist at the Gladstone Institute of Cardiovascular Disease at the University of California, San Francisco.

Mahley and his colleagues had begun studying apo E molecules long before genetic studies linked different forms of apo E to Alzheimer's disease. His group had learned that cholesterol-rich lipoprotein particles stimulate the growth of branches from developing axons. These researchers then observed that adding apo E-III to laboratory dishes of nerve cells causes axons to grow longer rather than to branch.

Substituting apo E-IV for apo E-III, however, stunts both types of axon growth, report Mahley, Gladstone's Britto P. Nathan, and their colleagues in the May 6 SCIENCE. "We find quite a striking difference [between the two]," says Mahley. In addition, unpublished work by this team suggests that apo E-IV leads to denser deposits of the beta-amyloid peptide implicated in Alzheimer's disease.

"To us, the [Gladstone] work is important because it demonstrates that there are isoform-specific effects on the development and growth of neurites [young axons]," comments Warren J. Strittmatter, a neuroscientist at Duke University Medical Center in Durham, N.C.

A Duke group has suggested that apo E-IV somehow fails to protect nerve cells in the same way that apo E-III can and therefore does not slow the progressive loss of brain function that eventually leads to Alzheimer's.

"This [report] could give insight into the neuronal mechanism," says Zaven S. Khachaturian of the National Institute on Aging in Bethesda, Md. The brains of people with apo E-IV may be less able to maintain or repair vital links between nerve cells.

When peripheral nerves are injured, white blood cells nearby make lots of apo E so they can take up lipids released by the deteriorating nerve cells, Mahley explains. Those lipids help rebuild nerve tissue. In addition, apo E-III may help cells construct and maintain microtubules, which make up an intracellular freight system for shuttling molecules to the far reaches of axons. By not playing that role, apo E-IV may impair nerve cells, Mahley and Strittmatter suggest.

In these experiments, apo E's effects depend on the presence of lipid particles. When the researchers added one type of apo E and no cholesterol-carrying particles to the nerve cells, the axons grew as if nothing had been added. Thus apo E must need to link with lipid particles in order to attach to docking sites on the cell's surface and get inside.

"We're beginning to unravel how apo E-III versus apo E-IV may impact the biology of the nervous system," Mahley concludes.
COPYRIGHT 1994 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:apolipoprotein
Author:Pennisi, Elizabeth
Publication:Science News
Date:May 7, 1994
Words:540
Previous Article:Cigarettes: are they doubly addictive?
Next Article:Temperatures on the rise in deep Atlantic.
Topics:


Related Articles
Artery clogging and APO-B.
Lipoprotein findings may solve one riddle ... and pose another.
Higher risk of Alzheimer's linked to gene.
A molecular whodunit: new twists in the Alzheimer's mystery.
Apo E: caught inside the nerve cell.
One team, two clues in Alzheimer's puzzle.
Gene for early, aggressive Alzheimer's.
Gene variants link Alzheimer's forms.
Alzheimer's Disease Genetics.
Molecule may protect against kidney damage.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |